Who is this study for?
The moment you receive a diagnosis of cancer – or any serious medical illness – time can feel like it stands still. It’s common to experience overwhelming emotions such as fear, sadness, or a deep sense of loss.
The REKINDLE study is exploring whether an investigational psychedelic treatment may support improved mental health for people experiencing depression or anxiety related to adjustment disorder following a major medical illness.
Adjustment disorder can show up in different ways for different people, but some of the more common signs include:
- Persistent sadness, crying or emotional numbness
- Loss of interest in daily activities
- Trouble sleeping or concentrating
- Overwhelming worry or fear
- Withdrawing from friends, family, or work
- Feeling hopeless about the future
What's involved?
If you, or someone you know is interested, the first step is a screening phone call with the Study Center to discuss whether the study may be a good fit.
If it seems to be a good fit, the next step is a visit to the Study Center for an in-person screening. This visit helps ensure that you continue to meet the eligibility criteria to participate.
You’ll also meet your Session Monitors – trained professionals who will be with you on your dosing day to provide guidance and support throughout your study participation.
Screening Period
Up to 28 Days
Dosing Visit
1 Day
Post-Dose Follow-up Period
6 Weeks
REKINDLE your resilience after diagnosis.
For those experiencing mental health struggles due to having cancer or other serious medical illnesses, The REKINDLE Research Study may help.
Why participate?
Access to Investigational Treatment
As part of this study, participants may receive an investigational psychedelic treatment.
No Cost Participation
Expert Care & Guidance
Each participant will be assigned a Session Monitor, a trained professional who will be present to provide guidance and support throughout the study sessions.
FAQ
What is Adjustment Disorder?
Adjustment disorder can be common during a serious illness, causing intense feelings of sadness, anxiety, hopelessness, or difficulty coping with daily life. With adjustment disorder, profound feelings of fear, anger, and loss are very common.
Adjustment disorder can look different for everyone, but common signs may include:
- Persistent sadness, crying or emotional numbness
- Loss of interest in daily activities
- Trouble sleeping or concentrating
Is there a charge to participate?
There is no charge to participate. Study Participants do not pay for the:
- Assigned study drug
- Clinic visits
- Study-related procedures, tests, or exams
What type of psychedelic medication is being evaluated?
The study drug is an investigational medication that is structurally similar to psilocybin (a drug with psychoactive properties) that may help ease psychiatric symptoms of adjustment disorder.
Including the Screening Period, the Dosing Visit, and the Post-Dose Follow-up Period, participation in this study will last up to ten weeks.
Why does this research matter?
Adjustment disorder can be common during a serious illness, causing intense feelings of sadness, anxiety, hopelessness, or difficulty coping with daily life. Unfortunately, there are currently no FDA-approved medications specifically for adjustment disorder related to serious illness.
Previous research with the psychedelic substance psilocybin has shown that it may rapidly improve anxiety and depressive symptoms, improve feelings of hopelessness and overall quality of life, and provide durable mental health relief to people with cancer.
Research studies like this one help us explore potential new treatments for emotional distress linked to major medical conditions. Your participation could help shape the future of care.
Submit Your Interest In Participating
Additional Eligibility Criteria Apply
"*" indicates required fields
